H5N1 clinical trials

Jun 18, 2020

Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19

Apr 23, 2020

ReiThera, LEUKOCARE and Univercells Announce Pan-European Consortium for the Fast-track Development of a Single-dose Adenovirus-based COVID-19 Vaccine

Apr 07, 2020

15 Prominent Pharma Companies in Vaccine Developments for COVID-19 - ResearchAndMarkets.com

Apr 02, 2020

Seed of hope: COVID-19 vaccine trials begin

Mar 11, 2020

Greffex, Inc. Completes COVID-19 Vaccine and Prepares for Testing

Mar 21, 2019

Last Participant out in USA Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate

Jan 10, 2019

Blue Water Vaccines Announces Transaction for Universal Influenza Vaccine with Oxford University

Apr 19, 2018

Sinovac Announces Preliminary Results of Phase III Trial on sIPV

Jan 08, 2018

Sabin To Tackle Pandemic Flu

Oct 26, 2017

The Human Vaccines Project Launches New Initiative To Accelerate Development Of Universally Effective Influenza Vaccines

Sep 26, 2017

Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine

Sep 06, 2017

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024